Endeavor Health

endeavorhealth.org

Live pipeline data from ClinicalTrials.gov, refreshed daily.

Total trials

113

Active

28

Phase 3

5

Total enrollment

726,514

Pipeline matrix

Showing 26 of 26 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Methadone7
Hydromorphone3
Dexamethasone2
Saline1
Naproxen Sodium 550mg1
Extended Release Acetaminophen1
Listed for each disorder below, up to three drugs per disorder1
Budesonide-albuterol1
Benralizumab1
Poractant Alfa1
Aprepitant1
Ondansetron1
Azelastine (137 mcg/spray) Nasal Spray and Mometasone (50 mcg/spray) Nasal Spray1
Mometasone Nasal Irrigation1
Mometasone (1 mg) and Azelastine (1 mg) Nasal Irrigation1
MIST surfactant1
Lovenox 40mg1
PRP Treatment1
HA Treatment1
Panzyga IVIG1
Zinc Citrate Oral1
Adalimumab1
Liposomal bupivacaine1
Carboplatin1
Paclitaxel1
Genetic Assessment1

Next readouts

  • 2020-08-12
  • 2021-05-25
  • 2025-08
  • 2025-12
  • 2025-12-30
  • 2025-12-31
  • 2026-03
  • 2026-04
  • 2026-12
  • 2026-12

Top conditions

  • Prostate Cancer4
  • Asthma4
  • Stress Urinary Incontinence3
  • Breast Cancer3
  • Dysmenorrhea3
  • Pelvic Pain3
  • Pain3
  • Postoperative Pain3

Frequently asked questions about Endeavor Health

How many clinical trials does Endeavor Health have on ClinicalTrials.gov?
Endeavor Health is listed as the lead sponsor on 113 clinical trials in ClinicalTrials.gov, 28 of which are currently active (recruiting, enrolling, or ongoing).
How many of Endeavor Health's trials are in Phase 3?
5 of Endeavor Health's trials are in Phase 3, spread across 26 active drug programs.
What therapeutic areas does Endeavor Health focus on?
Endeavor Health's most-studied conditions on ClinicalTrials.gov are Prostate Cancer, Asthma, Stress Urinary Incontinence, Breast Cancer, Dysmenorrhea.
When are Endeavor Health's next clinical trial readouts?
Endeavor Health has 10 upcoming primary-completion readouts tracked here; the soonest is “Effect of Methadone and Hydromorphone on the QT Interval After Anesthesia and Surgery”, expected around 2020-08-12.